- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Breast Cancer in United States
Total 26620 results
-
University of Michigan Rogel Cancer CenterAventis Pharmaceuticals; Rhone-Poulenc RorerCompletedMetastatic Breast CancerUnited States
-
Dartmouth-Hitchcock Medical CenterHoffmann-La RocheCompletedMetastatic Breast CancerUnited States
-
University of Michigan Rogel Cancer CenterTerminated
-
Memorial Sloan Kettering Cancer CenterContext Therapeutics Inc.WithdrawnMetastatic Breast Cancer | Unresectable Breast CancerUnited States
-
National Cancer Institute (NCI)TerminatedBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Hormone Receptor Negative Breast Cancer | HER2+ Breast CancerUnited States
-
University of MiamiRecruitingBreast Cancer | Metastatic Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Leptomeningeal Metastases | Recurrent Breast Cancer | Central Nervous System Metastases | Tumors Metastatic to BrainUnited States
-
Abramson Cancer Center at Penn MedicineActive, not recruitingAdvanced Breast Cancer | Metastatic Breast Cancer | BRCA1 Mutation | BRCA2 Mutation | Locally Advanced Breast CancerUnited States
-
Medical College of WisconsinLoyola University ChicagoRecruitingMetastatic Breast CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Foundation MedicineActive, not recruitingMetastatic Breast CancerUnited States
-
Joseph Baar, MD, PhDCompletedBreast Cancer | Metastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of Michigan; Queens Cancer Center of Queens HospitalCompletedMetastatic Breast Cancer | Central Nervous System (CNS) MetastasesUnited States
-
NYU Langone HealthNational Cancer Institute (NCI)CompletedBreast Cancer | Metastatic Breast Cancer | Recurrent Breast CancerUnited States
-
BriaCell Therapeutics CorporationLumaBridgeEnrolling by invitationBreast Cancer | Breast Neoplasm | Metastatic Breast Cancer | Breast Cancer MetastaticUnited States
-
Mayo ClinicRecruitingMetastatic Breast Cancer | HER2-negative Breast Cancer | Hormone-receptor-positive Breast CancerUnited States
-
University of RochesterJohns Hopkins UniversityCompletedMetastatic Breast Cancer | Breast Cancer Stage IVUnited States
-
QuantumLeap Healthcare CollaborativeRecruitingSolid Tumor | Metastatic Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Solid Tumor, Adult | Solid Carcinoma | HER2-positive Metastatic Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive... and other conditionsUnited States
-
Dana-Farber Cancer InstituteJohns Hopkins University; Translational Breast Cancer Research ConsortiumNot yet recruitingBreast Cancer | HER2-positive Breast Cancer | Stage IV Breast Cancer | Breast Cancer Female | Breast Cancer Metastatic | Estrogen Receptor-positive Breast CancerUnited States
-
Washington University School of MedicineBiovicaNot yet recruitingMetastatic Breast Cancer | Unresectable Breast CancerUnited States
-
A Bapsi Chakravarthy, MDCompletedResistant Breast Cancer | Non-metastatic Invasive Breast CancerUnited States
-
Dana-Farber Cancer InstituteAstraZenecaCompleted
-
Memorial Sloan Kettering Cancer CenterDuke UniversityCompleted
-
University of Kansas Medical CenterTerminatedMetastatic Breast CancerUnited States
-
University of VirginiaMerck Sharp & Dohme LLCRecruitingMetastatic Breast CancerUnited States
-
PfizerCompleted
-
PfizerActive, not recruitingMetastatic Breast CancerUnited States
-
Milton S. Hershey Medical CenterCompletedMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterSamus Therapeutics, Inc.CompletedMetastatic Breast CancerUnited States
-
Alaunos TherapeuticsCompletedMetastatic Breast CancerUnited States
-
Shannon PuhallaActive, not recruitingMetastatic Breast CancerUnited States
-
CelgeneTerminated
-
George Albert FisherEli Lilly and Company; Genentech, Inc.CompletedBreast Cancer | Metastatic Breast CancerUnited States
-
Northwestern UniversityAvon FoundationCompletedMetastatic Breast CancerUnited States
-
Veeda OncologyCelgene CorporationCompletedMetastatic Breast CancerUnited States
-
Southern Cancer CenterUniversity of South Alabama; Quantum Immunologics, Inc.UnknownMetastatic Breast CancerUnited States
-
Legacy Health SystemTerminatedMetastatic Breast CancerUnited States
-
University of PennsylvaniaActive, not recruitingBreast Neoplasm | Metastatic Breast Cancer | Estrogen Receptor Positive Breast CancerUnited States
-
Kathy MillerGenentech, Inc.RecruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | Estrogen-receptor-low Breast CancerUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.; Eisai Inc.TerminatedMetastatic Breast Cancer | HER2-positive Breast CancerUnited States
-
Indiana UniversityRecruitingBreast Cancer | Indolent Metastatic Breast CancerUnited States
-
AVEO Pharmaceuticals, Inc.CompletedMetastatic Breast CancerUnited States, Germany
-
University of MiamiRecruitingStage IV Breast Cancer | HER2-positive Metastatic Breast CancerUnited States
-
University of Wisconsin, MadisonRecruitingBreast Cancer | Metastatic Breast Cancer | HER2-negative Breast CancerUnited States
-
Dartmouth-Hitchcock Medical CenterRecruitingMetastatic Breast CancerUnited States
-
University of Michigan Rogel Cancer CenterTerminatedMetastatic Breast CancerUnited States
-
Michael Morse, MDGlaxoSmithKlineCompletedMetastatic Breast CancerUnited States
-
Washington University School of MedicineMerck Sharp & Dohme LLCTerminatedMetastatic Breast CancerUnited States
-
West Virginia UniversityOrtho Biotech, Inc.CompletedMetastatic Breast CancerUnited States
-
Immunovative Therapies, Ltd.WithdrawnMetastatic Breast CancerUnited States
-
Dartmouth-Hitchcock Medical CenterTerminated